A Risk Sciences International news item (Last modifed: August 18, 2019)

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

Posted in

More RSI News

RSI hosts Mitacs intern

September 7, 2020

Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at…

Read News Item

Dr. Mattison chairs NAM report

July 24, 2020

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the…

Read News Item

Country Foods Forum

March 1, 2020

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods…

Read News Item

Workshop on Evidence Integration December 5-6, 2019

November 11, 2019

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre…

Read News Item